Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: A meta-analysis of phase 3a trials

N. Freemantle, L. Meneghini, T. Christensen, M. L. Wolden, J. Jendle, R. Ratner

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint Dive into the research topics of 'Insulin degludec improves health-related quality of life (SF-36<sup>®</sup>) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: A meta-analysis of phase 3a trials'. Together they form a unique fingerprint.

Medicine & Life Sciences